US Stock MarketDetailed Quotes

Inovio Pharmaceuticals (INO)

Watchlist
  • 1.110
  • +0.020+1.83%
Close Apr 14 15:59 ET
  • 1.102
  • -0.008-0.75%
Post 19:08 ET
90.57MMarket Cap-0.61P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals (INO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-69.99%65.34K
0
0
0
65.34K
-73.83%217.76K
13.97%116.99K
0
-55.41%100.76K
0
Operating revenue
-69.99%65.34K
--0
--0
--0
--65.34K
-73.83%217.76K
13.97%116.99K
--0
-55.41%100.76K
--0
Cost of revenue
Gross profit
Operating expense
-22.85%86.89M
-14.69%17.48M
-22.44%21.21M
-30.67%23.08M
-20.23%25.12M
-16.12%112.62M
-25.49%20.49M
7.55%27.35M
-10.65%33.3M
-28.55%31.48M
Selling and administrative expenses
-11.67%32.68M
-5.07%7.22M
-8.55%7.88M
-16.10%8.56M
-14.63%9.02M
-22.25%37M
-25.79%7.6M
-13.21%8.61M
-24.52%10.21M
-23.90%10.57M
-General and administrative expense
-11.67%32.68M
-5.07%7.22M
-8.55%7.88M
-16.10%8.56M
-14.63%9.02M
-22.25%37M
-25.79%7.6M
-13.21%8.61M
-24.52%10.21M
-23.90%10.57M
Research and development costs
-28.32%54.21M
-20.37%10.26M
-28.83%13.33M
-37.11%14.52M
-23.06%16.09M
-12.76%75.62M
-25.31%12.89M
20.84%18.73M
-2.75%23.09M
-30.70%20.91M
Operating profit
22.76%-86.82M
14.20%-17.48M
22.44%-21.21M
30.46%-23.08M
20.44%-25.05M
15.76%-112.4M
25.64%-20.37M
-9.22%-27.35M
10.38%-33.2M
28.37%-31.48M
Net non-operating interest income expense
-47.26%2.42M
-47.30%449.34K
-50.11%552.11K
-53.29%610.64K
-38.90%808.08K
-33.59%4.59M
-44.52%852.59K
-31.90%1.11M
-29.51%1.31M
-30.16%1.32M
Non-operating interest income
-49.23%2.42M
-47.30%449.34K
-50.11%552.11K
-53.29%610.64K
-46.14%808.08K
-41.39%4.77M
-53.13%852.59K
-42.91%1.11M
-39.70%1.31M
-32.03%1.5M
Non-operating interest expense
--0
--0
--0
--0
--0
-85.46%177.83K
--0
--0
--0
-43.27%177.83K
Other net income (expense)
-197.90%-543.96K
15,268.01%20.79M
-2,410.02%-24.84M
-200.84%-1.05M
1,579.62%4.55M
106.46%555.64K
-84.14%135.3K
110.23%1.08M
0.18%-347.54K
-121.81%-307.36K
Gain on sale of security
-67.09%1.61M
588.93%21.18M
-1,776.46%-22.31M
-5,273.30%-1.12M
669.27%3.85M
-16.49%4.89M
59.42%3.07M
706.74%1.33M
-102.26%-20.82K
-84.44%500.88K
Earnings from equity interest
141.99%489.84K
61.95%-392.04K
-281.84%-589.62K
332.24%776.37K
651.61%695.13K
-250.87%-1.17M
-380.11%-1.03M
51.25%324.25K
-313.27%-334.29K
-120.44%-126.02K
Special income (charges)
----
----
----
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
----
----
----
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
16.50%-2.64M
100.00%88
-234.28%-1.94M
-9,387.85%-703.18K
99.93%-482
32.85%-3.16M
-121.77%-1.91M
-20,416.01%-579.82K
100.53%7.57K
71.88%-682.22K
Income before tax
20.80%-84.95M
119.42%3.76M
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
Income tax
Net income
20.80%-84.95M
119.42%3.76M
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
Net income continuous Operations
20.80%-84.95M
119.42%3.76M
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
Minority interest income
Net income attributable to the parent company
20.80%-84.95M
119.42%3.76M
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.80%-84.95M
119.42%3.76M
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
Basic earnings per share
54.18%-1.81
151.67%0.31
2.25%-0.87
48.74%-0.61
61.07%-0.51
35.14%-3.95
44.44%-0.6
41.45%-0.89
26.09%-1.19
30.69%-1.31
Diluted earnings per share
54.18%-1.81
151.67%0.31
2.25%-0.87
48.74%-0.61
61.07%-0.51
35.14%-3.95
44.44%-0.6
41.45%-0.89
26.09%-1.19
30.69%-1.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -69.99%65.34K00065.34K-73.83%217.76K13.97%116.99K0-55.41%100.76K0
Operating revenue -69.99%65.34K--0--0--0--65.34K-73.83%217.76K13.97%116.99K--0-55.41%100.76K--0
Cost of revenue
Gross profit
Operating expense -22.85%86.89M-14.69%17.48M-22.44%21.21M-30.67%23.08M-20.23%25.12M-16.12%112.62M-25.49%20.49M7.55%27.35M-10.65%33.3M-28.55%31.48M
Selling and administrative expenses -11.67%32.68M-5.07%7.22M-8.55%7.88M-16.10%8.56M-14.63%9.02M-22.25%37M-25.79%7.6M-13.21%8.61M-24.52%10.21M-23.90%10.57M
-General and administrative expense -11.67%32.68M-5.07%7.22M-8.55%7.88M-16.10%8.56M-14.63%9.02M-22.25%37M-25.79%7.6M-13.21%8.61M-24.52%10.21M-23.90%10.57M
Research and development costs -28.32%54.21M-20.37%10.26M-28.83%13.33M-37.11%14.52M-23.06%16.09M-12.76%75.62M-25.31%12.89M20.84%18.73M-2.75%23.09M-30.70%20.91M
Operating profit 22.76%-86.82M14.20%-17.48M22.44%-21.21M30.46%-23.08M20.44%-25.05M15.76%-112.4M25.64%-20.37M-9.22%-27.35M10.38%-33.2M28.37%-31.48M
Net non-operating interest income expense -47.26%2.42M-47.30%449.34K-50.11%552.11K-53.29%610.64K-38.90%808.08K-33.59%4.59M-44.52%852.59K-31.90%1.11M-29.51%1.31M-30.16%1.32M
Non-operating interest income -49.23%2.42M-47.30%449.34K-50.11%552.11K-53.29%610.64K-46.14%808.08K-41.39%4.77M-53.13%852.59K-42.91%1.11M-39.70%1.31M-32.03%1.5M
Non-operating interest expense --0--0--0--0--0-85.46%177.83K--0--0--0-43.27%177.83K
Other net income (expense) -197.90%-543.96K15,268.01%20.79M-2,410.02%-24.84M-200.84%-1.05M1,579.62%4.55M106.46%555.64K-84.14%135.3K110.23%1.08M0.18%-347.54K-121.81%-307.36K
Gain on sale of security -67.09%1.61M588.93%21.18M-1,776.46%-22.31M-5,273.30%-1.12M669.27%3.85M-16.49%4.89M59.42%3.07M706.74%1.33M-102.26%-20.82K-84.44%500.88K
Earnings from equity interest 141.99%489.84K61.95%-392.04K-281.84%-589.62K332.24%776.37K651.61%695.13K-250.87%-1.17M-380.11%-1.03M51.25%324.25K-313.27%-334.29K-120.44%-126.02K
Special income (charges) ----------------------0--0--0--------
-Less:Impairment of capital assets ----------------------0--0--0--------
Other non- operating income (expenses) 16.50%-2.64M100.00%88-234.28%-1.94M-9,387.85%-703.18K99.93%-48232.85%-3.16M-121.77%-1.91M-20,416.01%-579.82K100.53%7.57K71.88%-682.22K
Income before tax 20.80%-84.95M119.42%3.76M-80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M
Income tax
Net income 20.80%-84.95M119.42%3.76M-80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M
Net income continuous Operations 20.80%-84.95M119.42%3.76M-80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M
Minority interest income
Net income attributable to the parent company 20.80%-84.95M119.42%3.76M-80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.80%-84.95M119.42%3.76M-80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M
Basic earnings per share 54.18%-1.81151.67%0.312.25%-0.8748.74%-0.6161.07%-0.5135.14%-3.9544.44%-0.641.45%-0.8926.09%-1.1930.69%-1.31
Diluted earnings per share 54.18%-1.81151.67%0.312.25%-0.8748.74%-0.6161.07%-0.5135.14%-3.9544.44%-0.641.45%-0.8926.09%-1.1930.69%-1.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -